etrials and Omnicare Clinical Research Sign Licensing Agreement
Multi-Year Subscription to Simplify and Accelerate Clinical Trial Research
Morrisville, NC--April 25, 2005--etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, announced today that Omnicare Clinical Research, a subsidiary of Omnicare, Inc. and provider of drug development services to pharmaceutical, biotechnology and medical device companies, has signed a multi-year, subscription licensing agreement that will enable its clients to utilize etrials' eClinical platform for collecting, monitoring and analyzing clinical trial data.
Using these tools, Omnicare will develop and tailor studies for its clients to improve patient enrollment, provide access to cleaner data faster and shorten study timelines. etrials' easy-to-use, fully integrated technologies will help meet the eClinical needs of Omnicare's clients who conduct clinical trials of all sizes and complexities in a wide variety of therapeutic areas. To date, the companies have already begun work on two studies utilizing etrials' eClinical Suite of products.
"Progressive CROs like Omnicare have continued to try and distinguish themselves in the market by seeking out the best new technology offerings for their clients. By offering tools to expedite data collection and ultimately their clients' trials, Omnicare is ahead of the curve," said John Cline, CEO of etrials. "Our first cooperative trial with Omnicare, which is for a top-ten pharmaceutical company, serves as an example that the industry now recognizes the importance of eClinical technologies in trial research."
About etrials Worldwide, Inc.
etrials is a software and services company dedicated to making eClinical easy. We are the first company to offer a fully integrated suite of eClinical software including electronic data capture (EDC), electronic patient reported outcomes (ePRO), interactive voice response (IVR) and analytics to support the entire clinical trial process, from collection and cleaning to the integration and review of data. Our expertise includes studies from Phase I to post-approval for pharmaceutical, biotechnology and clinical research organizations. To date, our team of professionals has participated in over 450 clinical trials in more than 50 different countries.
etrials makes easy-to-use technologies supported by people who are just as easy to work with. Visit us at www.etrials.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
